PT1121127E - Composicoes farmaceuticas orais contendo buprenorfina - Google Patents

Composicoes farmaceuticas orais contendo buprenorfina

Info

Publication number: PT1121127E
Authority: PT; Portugal
Prior art keywords: orais; buprenorfin; pharmaceutical compositions; pharmaceutically acceptable; pharmaceutical composition
Prior art date: 1998-10-16

Application number

PT99950690T

Other languages

English (en)

Inventor

Mauro Valenti

Original Assignee

Formenti Farmaceutici Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

1999-10-11

Publication date

2005-03-31

1999-10-11 Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa

2005-03-31 Publication of PT1121127E publication Critical patent/PT1121127E/pt

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003963 antioxidant agent Substances 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 abstract 1
239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

PT99950690T 1998-10-16 1999-10-11 Composicoes farmaceuticas orais contendo buprenorfina PT1121127E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1998MI002222A IT1302682B1 (it)	1998-10-16	1998-10-16	Composizioni farmaceutiche orali contenenti buprenorfina

Publications (1)

Publication Number	Publication Date
PT1121127E true PT1121127E (pt)	2005-03-31

Family

ID=11380880

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99950690T PT1121127E (pt)	1998-10-16	1999-10-11	Composicoes farmaceuticas orais contendo buprenorfina

Country Status (15)

Country	Link
US (1)	US6365596B1 (pt)
EP (1)	EP1121127B1 (pt)
JP (1)	JP2002527480A (pt)
AT (1)	ATE287264T1 (pt)
AU (1)	AU752449B2 (pt)
CA (1)	CA2347195C (pt)
DE (1)	DE69923336T2 (pt)
DK (1)	DK1121127T3 (pt)
ES (1)	ES2237165T3 (pt)
HU (1)	HU226166B1 (pt)
IT (1)	IT1302682B1 (pt)
NZ (1)	NZ511085A (pt)
PT (1)	PT1121127E (pt)
SI (1)	SI1121127T1 (pt)
WO (1)	WO2000023079A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ528064A (en) *	2001-02-16	2006-03-31	Gruenenthal Chemie	Utilization of buprenorphine in urinary incontinence therapy
US20140271788A1 (en)	2013-03-15	2014-09-18	Monosol Rx, Llc	Sublingual and buccal film compositions
WO2006097793A2 (en)	2004-04-15	2006-09-21	Chiasma, Ltd.	Compositions capable of facilitating penetration across a biological barrier
DE602004017514D1 (de) *	2004-06-02	2008-12-11	Galephar M F	Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
BRPI0618891A2 (pt) *	2005-11-21	2011-09-13	Schering-Plough Ltd.	composições farmacêuticas
EP1897543A1 (en)	2006-08-30	2008-03-12	Euro-Celtique S.A.	Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) *	2006-10-18	2009-10-29	Clive Booles	Novel compositions and formulations
US20090082383A1 (en) *	2007-09-26	2009-03-26	Protia, Llc	Deuterium-enriched buprenorphine
ES3058497T3 (en)	2008-09-17	2026-03-11	Amryt Endo Inc	Pharmaceutical compositions comprising polypeptides and related methods of delivery
GB2469792A (en) *	2009-04-23	2010-11-03	Calvin John Ross	Oil-based pharmaceutical formulation for sublingual delivery
PH12014500316B1 (en)	2011-09-19	2018-10-03	Orexo Ab	New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US9839611B2 (en)	2013-09-10	2017-12-12	Insys Development Company, Inc.	Sublingual buprenorphine spray
US9918981B2 (en)	2013-09-10	2018-03-20	Insys Development Company, Inc.	Liquid buprenorphine formulations
EP3043777B1 (en)	2013-09-10	2020-04-22	Fresh Cut Development, LLC	Sublingual buprenorphine spray
US9867818B2 (en)	2013-09-10	2018-01-16	Insys Development Company, Inc.	Sublingual buprenorphine spray
US10722510B2 (en)	2014-07-08	2020-07-28	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
US10617686B2 (en)	2014-07-08	2020-04-14	Hikma Pharmaceuticals Usa Inc.	Liquid naloxone spray
WO2016007245A1 (en)	2014-07-08	2016-01-14	Insys Pharma, Inc.	Sublingual naloxone spray
PL3253401T3 (pl)	2015-02-03	2025-08-04	Amryt Endo, Inc.	Leczenie akromegalii oktreotydem doustnym
ES2965836T3 (es)	2018-01-22	2024-04-17	Foresee Pharmaceuticals Co Ltd	Composición farmacéutica para administración de liberación mantenida de buprenorfina
US11141457B1 (en)	2020-12-28	2021-10-12	Amryt Endo, Inc.	Oral octreotide therapy and contraceptive methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4605671A (en) *	1984-09-28	1986-08-12	American Home Products Corporation	Parenteral formulation
JPH03275622A (ja) *	1990-03-26	1991-12-06	Teisan Seiyaku Kk	マレイン酸トリメブチンを含有する経口固形製剤
JPH08295637A (ja) *	1995-04-27	1996-11-12	Green Cross Corp:The	口腔部局所投与剤
PT914097E (pt) *	1996-03-12	2002-06-28	Alza Corp	Composicao e forma de dosagem compreendendo antagonista de opioide
JP3687025B2 (ja) *	1998-06-04	2005-08-24	東和薬品株式会社	安定なマレイン酸エナラプリル錠剤

1998
- 1998-10-16 IT IT1998MI002222A patent/IT1302682B1/it active IP Right Grant
1999
- 1999-10-11 DK DK99950690T patent/DK1121127T3/da active
- 1999-10-11 AT AT99950690T patent/ATE287264T1/de active
- 1999-10-11 NZ NZ511085A patent/NZ511085A/xx not_active IP Right Cessation
- 1999-10-11 SI SI9930736T patent/SI1121127T1/xx unknown
- 1999-10-11 HU HU0103924A patent/HU226166B1/hu not_active IP Right Cessation
- 1999-10-11 DE DE69923336T patent/DE69923336T2/de not_active Expired - Lifetime
- 1999-10-11 CA CA002347195A patent/CA2347195C/en not_active Expired - Lifetime
- 1999-10-11 US US09/807,216 patent/US6365596B1/en not_active Expired - Lifetime
- 1999-10-11 AU AU63371/99A patent/AU752449B2/en not_active Ceased
- 1999-10-11 ES ES99950690T patent/ES2237165T3/es not_active Expired - Lifetime
- 1999-10-11 EP EP99950690A patent/EP1121127B1/en not_active Expired - Lifetime
- 1999-10-11 PT PT99950690T patent/PT1121127E/pt unknown
- 1999-10-11 JP JP2000576853A patent/JP2002527480A/ja active Pending
- 1999-10-11 WO PCT/EP1999/007595 patent/WO2000023079A1/en not_active Ceased

Also Published As

Publication number	Publication date
ITMI982222A0 (it)	1998-10-16
ATE287264T1 (de)	2005-02-15
US6365596B1 (en)	2002-04-02
DE69923336T2 (de)	2005-05-25
HUP0103924A3 (en)	2003-05-28
CA2347195C (en)	2008-03-18
SI1121127T1 (en)	2005-06-30
ES2237165T3 (es)	2005-07-16
ITMI982222A1 (it)	2000-04-16
HUP0103924A2 (hu)	2002-02-28
EP1121127A1 (en)	2001-08-08
HU226166B1 (en)	2008-05-28
IT1302682B1 (it)	2000-09-29
CA2347195A1 (en)	2000-04-27
EP1121127B1 (en)	2005-01-19
AU752449B2 (en)	2002-09-19
NZ511085A (en)	2002-10-25
WO2000023079A1 (en)	2000-04-27
DE69923336D1 (de)	2005-02-24
JP2002527480A (ja)	2002-08-27
DK1121127T3 (da)	2005-05-02
AU6337199A (en)	2000-05-08

Similar Documents

Publication	Publication Date	Title
NO2025027I1 (no)	2025-06-13	Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
IT1302682B1 (it)	2000-09-29	Composizioni farmaceutiche orali contenenti buprenorfina
BG66093B1 (bg)	2011-04-29	Състави с контролирано освобождаване, съдържащи нимесулид
AU2003303458A1 (en)	2004-07-22	Ampholytic copolymer and use thereof
BR9810495A (pt)	2000-09-12	Composição farmacêutica
TW200633716A (en)	2006-10-01	Compositions and methods for stabilizing active pharmaceutical ingredients
BR0306870A (pt)	2004-11-03	Composição farmacêutica oral, e, método para preparar a mesma
MXPA03007857A (es)	2004-05-24	Compuestos y composiciones para entregar agentes activos.
ZA200410211B (en)	2005-09-06	Quinuclidine derivatives and pharmaceutical compositions containing the same.
HUP0400832A3 (en)	2004-10-28	New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
PL375874A1 (pl)	2005-12-12	Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
IT1320080B1 (it)	2003-11-18	Composizione per uso farmaceutico o dietetico.
IL164440A0 (en)	2005-12-18	New pharmaceutical composition containing fibanserin polymorph a
AU2002309038A1 (en)	2003-05-01	Compositions for transmucosal administration containing coenzyme Q as the active ingredient
PL348419A1 (en)	2002-05-20	Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
SE9802208D0 (sv)	1998-06-22	Novel compounds
TW200509992A (en)	2005-03-16	Dosage form containing pantoprazole as active ingredient
ATE268175T1 (de)	2004-06-15	Decursin-enthaltende pharmazeutische zusammensetzungen
HUP0303673A3 (en)	2010-04-28	Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient
WO2004098577A3 (en)	2004-12-09	Dosage form containing (s)-pantoprazole as active ingredient
AU4317500A (en)	2001-11-12	Antibiral compositions containing phorbol derivatives as the main active ingredient
SE9802209D0 (sv)	1998-06-22	Novel compounds
ATE412404T1 (de)	2008-11-15	Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2003061572A8 (en)	2004-10-28	Anti-inflammatory formulations
EP1273301A3 (en)	2003-04-09	Pharmaceutical preparations based on active ingredients susceptible to illict administration